Aquestive reports positive human factors and PK results for Anaphylm film
Aquestive Therapeutics announced positive human factors and pharmacokinetic study results for its Anaphylm (dibutepinephrine) sublingual film, supporting its planned NDA resubmission in Q3 2026.
View filing at SEC.gov →